Psychiatric Illness or Immune Dysfunction-Brain Perfusion Imaging Providing the Answer in a Case of Anti-NMDAR Encephalitis.
SPECT
anti-NMDAR encephalitis
quantification
schizophrenia
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
30 Sep 2022
30 Sep 2022
Historique:
received:
17
08
2022
revised:
21
09
2022
accepted:
28
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
We investigated the potential use of SPECT quantification in addition to qualitative brain perfusion analysis for the detection of anti-NMDAR encephalitis. The question is how to normalize brain activity to be able to quantitatively detect perfusion patterns. Usually, brain activity is normalized to a structure considered unaffected by the disease. Brain [99mTc]-HMPAO SPECT was performed as a method to detect brain perfusion patterns. The patterns of abnormal brain perfusion cannot always be reliably and qualitatively assessed when dealing with rare diseases. Recent advances in SPECT quantification using commercial software have enabled more objective and detailed analysis of brain perfusion. The cerebellum and whole brain were used as the normalization structures and were compared with visual analysis. The quantification analysis performed with whole brain normalization confirmed right parietal lobe hypoperfusion while also detecting statistically significant left-to-right perfusion differences between the temporal lobe and thalamus. Whole brain normalization further described bilateral frontal lobe hyperperfusion, predominantly of the left lobe, and was in accordance with visual analysis. SPECT quantitative brain perfusion analysis, using the whole brain as the normalization structure rather than the cerebellum, in this case, improved confidence in the visual detection of anti-NMDAR encephalitis and provided unexpected solutions to atypical psychiatric dilemmas.
Sections du résumé
BACKGROUND
BACKGROUND
We investigated the potential use of SPECT quantification in addition to qualitative brain perfusion analysis for the detection of anti-NMDAR encephalitis. The question is how to normalize brain activity to be able to quantitatively detect perfusion patterns. Usually, brain activity is normalized to a structure considered unaffected by the disease.
METHODS
METHODS
Brain [99mTc]-HMPAO SPECT was performed as a method to detect brain perfusion patterns. The patterns of abnormal brain perfusion cannot always be reliably and qualitatively assessed when dealing with rare diseases. Recent advances in SPECT quantification using commercial software have enabled more objective and detailed analysis of brain perfusion. The cerebellum and whole brain were used as the normalization structures and were compared with visual analysis.
RESULTS
RESULTS
The quantification analysis performed with whole brain normalization confirmed right parietal lobe hypoperfusion while also detecting statistically significant left-to-right perfusion differences between the temporal lobe and thalamus. Whole brain normalization further described bilateral frontal lobe hyperperfusion, predominantly of the left lobe, and was in accordance with visual analysis.
CONCLUSION
CONCLUSIONS
SPECT quantitative brain perfusion analysis, using the whole brain as the normalization structure rather than the cerebellum, in this case, improved confidence in the visual detection of anti-NMDAR encephalitis and provided unexpected solutions to atypical psychiatric dilemmas.
Identifiants
pubmed: 36292066
pii: diagnostics12102377
doi: 10.3390/diagnostics12102377
pmc: PMC9600880
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Lancet Neurol. 2013 Feb;12(2):157-65
pubmed: 23290630
Psychosomatics. 2020 Jan - Feb;61(1):39-48
pubmed: 31611047
Front Neuroinform. 2018 Dec 10;12:94
pubmed: 30618699
Neurology. 2008 Feb 12;70(7):504-11
pubmed: 17898324
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Trends Neurosci. 2016 May;39(5):300-310
pubmed: 27130657
J Neurol. 2011 Apr;258(4):686-8
pubmed: 20972895
JAMA Psychiatry. 2013 Mar;70(3):271-8
pubmed: 23344076
Case Rep Neurol. 2017 Nov 23;9(3):272-276
pubmed: 29515425
Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86
pubmed: 24687634
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
Rinsho Shinkeigaku. 2008 Mar;48(3):196-201
pubmed: 18409540
Adv Exp Med Biol. 2017;956:239-259
pubmed: 27888488
Neurologia (Engl Ed). 2018 Nov - Dec;33(9):622-623
pubmed: 27452621
Endocr Pract. 2015 Apr;21(4):406-12
pubmed: 25716634
AJNR Am J Neuroradiol. 2017 Jun;38(6):1070-1078
pubmed: 28183838
Neuroimage. 2002 Nov;17(3):1193-202
pubmed: 12414259
Ann Neurol. 2009 Jul;66(1):11-8
pubmed: 19670433
Handb Clin Neurol. 2013;112:1229-33
pubmed: 23622333
Brain Nerve. 2008 Sep;60(9):1047-60
pubmed: 18807939
JAMA Neurol. 2013 Sep 1;70(9):1133-9
pubmed: 23877059
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):195-8
pubmed: 21933952
Front Neurol. 2022 Jul 25;13:892242
pubmed: 35959389
J Nucl Med. 2009 May;50 Suppl 1:11S-20S
pubmed: 19380405
Surg Oncol Clin N Am. 2016 Jan;25(1):119-38
pubmed: 26610778
Neuroimage. 2008 Apr 1;40(2):529-540
pubmed: 18258457
Ann Neurol. 2005 Oct;58(4):594-604
pubmed: 16178029
Clin Neurol Neurosurg. 2014 Mar;118:44-8
pubmed: 24529228
Brain Behav. 2020 Mar;10(3):e01540
pubmed: 31985135
Neurologia. 2010 Sep;25(7):409-13
pubmed: 20964986
Brain Dev. 2013 Feb;35(2):181-4
pubmed: 22554905
N Engl J Med. 2018 Mar 1;378(9):840-851
pubmed: 29490181
Psychosomatics. 2015 May-Jun;56(3):227-41
pubmed: 25975857
Dev Med Child Neurol. 2017 Aug;59(8):796-805
pubmed: 28439890
Endocr Regul. 2019 Jul 1;53(3):191-212
pubmed: 31517632
Lancet Neurol. 2014 Feb;13(2):167-77
pubmed: 24360484